Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Harlin

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Protocols in Cytometry|September 5, 2008
Diagnosis and treatment of mycoplasma-contaminated cell culturesHelena Harlin, Thomas F Gajewski
Current Protocols in Microbiology|September 5, 2008
Diagnosis and treatment of Mycoplasma-contaminated cell culturesHelena Harlin, Thomas F Gajewski
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2006
Immune suppression in the tumor microenvironmentThomas F Gajewski, Yuru Meng, Helena Harlin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanomaAmy C Peterson, Helena Harlin, Thomas F Gajewski
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2002
TCR-independent CD30 signaling selectively induces IL-13 production via a TNF receptor-associated factor/p38 mitogen-activated protein kinase-dependent mechanismHelena Harlin, Eckhard Podack, Mark Boothby, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
Induction of cytotoxic granules in human memory CD8+ T cell subsets requires cell cycle progressionYuru Meng, Helena Harlin, James P O'Keefe, et al.
Analytical and Quantitative Cytology and Histology|May 1, 2009
Expression of immunomodulating genes in prostate cancer and benign prostatic tissueAnca Reschner, Helena Harlin, Brett Laven, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2006
Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascitesHelena Harlin, Todd V Kuna, Amy C Peterson, et al.
Journal of Leukocyte Biology|July 2, 2003
Disparate functions of immature and mature human myeloid dendritic cells: implications for dendritic cell-based vaccinesKatharina Tschoep, Thomas C Manning, Helena Harlin, et al.
Immunological Reviews|September 16, 2006
Immune resistance orchestrated by the tumor microenvironmentThomas F Gajewski, Yuru Meng, Christian Blank, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Protocols in Cytometry|September 5, 2008
Diagnosis and treatment of mycoplasma-contaminated cell culturesHelena Harlin, Thomas F Gajewski
Current Protocols in Microbiology|September 5, 2008
Diagnosis and treatment of Mycoplasma-contaminated cell culturesHelena Harlin, Thomas F Gajewski
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2006
Immune suppression in the tumor microenvironmentThomas F Gajewski, Yuru Meng, Helena Harlin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanomaAmy C Peterson, Helena Harlin, Thomas F Gajewski
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2002
TCR-independent CD30 signaling selectively induces IL-13 production via a TNF receptor-associated factor/p38 mitogen-activated protein kinase-dependent mechanismHelena Harlin, Eckhard Podack, Mark Boothby, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
Induction of cytotoxic granules in human memory CD8+ T cell subsets requires cell cycle progressionYuru Meng, Helena Harlin, James P O'Keefe, et al.
Analytical and Quantitative Cytology and Histology|May 1, 2009
Expression of immunomodulating genes in prostate cancer and benign prostatic tissueAnca Reschner, Helena Harlin, Brett Laven, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2006
Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascitesHelena Harlin, Todd V Kuna, Amy C Peterson, et al.
Journal of Leukocyte Biology|July 2, 2003
Disparate functions of immature and mature human myeloid dendritic cells: implications for dendritic cell-based vaccinesKatharina Tschoep, Thomas C Manning, Helena Harlin, et al.
Immunological Reviews|September 16, 2006
Immune resistance orchestrated by the tumor microenvironmentThomas F Gajewski, Yuru Meng, Christian Blank, et al.
Pageof 2